Challenges & Trends In Stem Cell-Derived Extracellular Vesicle Bioprocessing

Exosomes derived from mesenchymal stem cells (MSC) are a novel and trending alternative to restoring tissues and organs, avoiding the limitations typically associated with stem cell therapy. According to Pubmed, the number of citations on exosome research has grown more than ten times in the last decade! Application scientist, Dr. Jorge Escobar Ivirico, explains and underscores the key differences with the production of exosomes from other cellular therapies.

Originally published by Cell & Gene Therapy Insights